Real-World Data from OneOncology Practices Show Tarlatamab Can Be Administered Safely in the Outpatient Community Oncology Setting

Analysis of 90 patients with small cell lung cancer found mostly low-grade cytokine release syndrome and neurotoxicity across outpatient, inpatient, and hybrid care models NASHVILLE, Tenn., Oct. 27, 2026 /PRNewswire/ -- OneOncology today announced results from a real-world retrospective...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.